Gerry Gould Joins Haemonetics as Vice President, Investor Relations

^{Published on 2011-08-29 19:01:24 - Market Wire}
 

Gerry Gould Joins Haemonetics as Vice President, Investor Relations -- BRAINTREE, Mass., Aug. 29, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about HAE

BRAINTREE, Mass., Aug. 29, 2011 /PRNewswire/ -- Haemonetics Corporation (NYSE: [ HAE ]) announced that Gerry Gould has joined Haemonetics effective today as Vice President, Investor Relations, reporting to CFO & Vice President Business Development, Chris Lindop.

Mr. Gould was formerly Vice President, Investor Relations at RSC Equipment Rental and previously was Vice President, Investor Relations for Stanley Works, now Stanley Black& Decker.

Gerry is a graduate of Leonard N. Stern Graduate Business School, New York University, New York, where he earned his Master's Degree in Accountancy.  Gerry also holds his Bachelor's Degree in Business Administration and French from St. Michael's College.  He is an active member of the National Investor Relations Institute ("NIRI") and the NIRI Senior Roundtable.

Mr. Lindop said "It is a great pleasure to welcome Gerry to Haemonetics.  He is a seasoned IR professional with a wealth of experience gained over his long career working with Wall Street.  We look forward to working with Gerry to continue Haemonetics long tradition of transparency and accountability to our investors while benefiting from his past experiences and existing investor relationships."

Mr. Gould can be reached at 781-356-9402 or at [ gerry.gould@haemonetics.com ].

Haemonetics (NYSE: [ HAE ]) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at [ http://www.haemonetics.com ].

CONTACT:
Bryanne Salmon
Tel. (781) 356-9613
[ bsalmon@haemonetics.com ]

SOURCE Haemonetics Corporation

RELATED LINKS
[ http://www.haemonetics.com ]